Quiz: Radionuclide Therapy

According to the Society of Nuclear Medicine “SNM Procedure Guideline for Therapy of Thyroid Disease with I-131 (Sodium Iodide),” typically administered activity for treatment of presumed thyroid cancer in the neck or mediastinal lymph nodes is in the range:

Iodine-131 is considered to be the treatment of choice in many patients with Graves’ disease. The most common side effect of radioactive iodine (RAI) treatment is:

What is the predominant toxicity of radioisotopes used in the treatment of bone metastases?

The form of targeted radionuclide therapy that uses a monoclonal antibody to deliver localized radiation is called:

An ultimate treatment for patients who are nonresponsive to or cannot tolerate other available therapies for a particular illness and whose prognosis is often poor is called:

Treatment of hyperthyroidism with antithyroid medications must be given for 6 months to 2 years, in order to be effective. The two main antithyroid drugs are:

Samarium-153 (Quadramet) is a therapeutic radiopharmaceutical used to treat:

A lone “cold” nodule in an otherwise normal thyroid gland warrants:

Transient increase in tracer uptake in responding metastases in the early months after chemotherapy/hormone therapy for breast and prostate cancer is called:

Which of the following time is advised for patients treated with 1-131 to delay conception after treatment?